Christian Angermayer

Christian Angermayer invests in life sciences, fintech, AI, psychedelics and cryptocurrencies through his family office Apeiron Investment Group.

He made his first millions cofounding biotech firm Ribopharma with his college professors; he sold his stake when it merged with Alnylam in 2003.

His Malta-based Apeiron owns shares in several publicly traded firms and private companies in the U.S., Germany, Canada and Australia.

His holdings include psychedelics biopharma firm Atai Life Sciences and blockchain holding company Samara, alongside co-investor Mike Novogratz.

He owns an extensive art collection that includes ancient artifacts highlighting the role that psychedelics have played in human history.